GD
41
-4
DIS
85
3
ROST
57
-3
ALL
50
2
OI
42
-3
AVGO
18
-9
MCO
71
-7
MTCH
20
-8
M
31
-3
GOOG
57
-6
COST
57
-6
PG
50
2
PDCO
29
2
SWKS
38
-2
ILMN
32
-9
ADP
65
-3
NI
72
4
ADM
28
3
WEC
53
5
USB
50
-3
GD
41
-4
DIS
85
3
ROST
57
-3
ALL
50
2
OI
42
-3
AVGO
18
-9
MCO
71
-7
MTCH
20
-8
M
31
-3
GOOG
57
-6
COST
57
-6
PG
50
2
PDCO
29
2
SWKS
38
-2
ILMN
32
-9
ADP
65
-3
NI
72
4
ADM
28
3
WEC
53
5
USB
50
-3
Financhill
Back

ManpowerGroup Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
30

MAN
ManpowerGroup

Last Price:
62.28
Seasonality Move:
5.13%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
42.56
Seasonality Move:
17.03%
Sell
30
ManpowerGroup (MAN) is a Sell

Is ManpowerGroup a Buy, Sell or Hold?

  • The current ManpowerGroup [MAN] share price is $61.70. The Score for MAN is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • MAN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MAN Stock Price Chart

What is ManpowerGroup's stock price today?

  • The ManpowerGroup share price today is $61.70
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MAN is experiencing selling pressure, which indicates risk of future bearish movement.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

MAN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.51 Sell
Relative Strength Index (14 RSI): 35.34 Sell
Chaikin Money Flow: -441398 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.59 - 68.45) Sell
Bollinger Bands (100): (66.21 - 73.77) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

MAN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64 Sell
20-day SMA: 63.5 Sell
50-day SMA: 68.44 Sell
200-day SMA: 71.93 Sell
8-day EMA: 63.4 Sell
20-day EMA: 64.62 Sell
50-day EMA: 67.25 Sell
200-day EMA: 71.42 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

ManpowerGroup Earnings Growth & MAN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.13 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.22 per share, and an increase next year of $0.65 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

ManpowerGroup Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):